Increase in the effectiveness of melphalan therapy with progression of MOPC-315 plasmacytoma tumor growth

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells.

1982 • 640 citations

Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes.

1981 • 317 citations

Cooperation between cyclophosphamide tumoricidal activity and host antitumor immunity in the cure of mice bearing large MOPC-315 tumors.

1981 • 100 citations

Importance of timing in cyclophosphamide therapy of MOPC-315 tumor-bearing mice.

1980 • 92 citations

Mutagenesis of Mouse Myeloma Cells with ‘Melphalan’

1973 • 61 citations

Role of antitumor immunity in cyclophosphamide-induced rejection of subcutaneous nonpalpable MOPC-315 tumors.

1982 • 59 citations

Tumor Immunity to Murine Plasma Cell Tumors. I. Tumor-Associated Transplantation Antigens of NZB and BALB/c Plasma Cell Tumors 2 3

1973 • 55 citations

ADOPTIVE CHEMOIMMUNOTHERAPY OF CANCER IN ANIMALS: A REVIEW OF RESULTS, PRINCIPLES, AND PROBLEMS*

1976 • 51 citations

Contribution of host immunity to cyclophosphamide therapy of a chemically‐induced murine sarcoma

1973 • 51 citations

Detection of early and delayed antitumor effects following curative adoptive chemoimmunotherapy of established leukemia.

1980 • 49 citations

Host immune potentiation of drug responses to a murine mammary adenocarcinoma

1976 • 43 citations

The development of in vitro and in vivo anti-tumor cytotoxicity in noncytotoxic, MOPC-315-tumor-bearer, spleen cells ?educated? in vitro with MOPC-315 tumor cells

1978 • 42 citations

A method for the measurement of L-phenylalanine mustard in the mouse and dog by high-pressure liquid chromatography.

1976 • 41 citations

Effectiveness of murine leukemia chemotherapy according to the immune state

1977 • 37 citations

Therapy of the Murine Plasmacytoma MOPC 104E: Role of the Immune Response<xref ref-type="fn" rid="FN2">2</xref>

1978 • 28 citations

Differential tumor immunogenicity of L1210 and its sublines. I. Effect of an increased antigen density on tumor cell surfaces on primary B cell responses in vitro.

1977 • 28 citations

INDUCTION OF TUMOR IMMUNITY BY INTRATUMORAL CHEMOTHERAPY

1976 • 27 citations

Effect of L-phenylalanine mustard, adriamycin, actinomycin D, and 4'-(9-acridinylamino)methanesulfon-m-anisidide on naturally occurring human spontaneous monocyte-mediated cytotoxicity.

1982 • 27 citations

Analysis of synergy between cyclophosphamide Therapy and Immunity Against a Mouse Tumour

1978 • 25 citations

Augmentation of antitumor cytotoxicity of MOPC-315 tumor bearer spleen cells by depletion of dinitrophenol-adherent cells prior to in vitro immunization.

1979 • 22 citations

Effectiveness of Murine Leukemia Chemotherapy According to the Immune State: Reconsideration of Correlations Between Chemotherapy, Tumour Cell Killing, and Survival Time

1977 • 19 citations

Differential Tumor Immunogenicity of DBA/2 Mouse Lymphoma L1210 and Its Sublines. II. Increased Expression of Tumor-Associated Antigens on Subline Cells Recognized by Serologic and Transplantation Methods<xref ref-type="fn" rid="FN2">2</xref>

1979 • 18 citations

The allogeneic effect on tumor growth. I. Inhibition of a murine plasmacytoma, MOPC 315, by the graft-vs-host reaction.

1977 • 14 citations

Collaboration between specific anti-tumor immunity and chemotherapeutic agents

1980 • 10 citations

Potentiation of the cytotoxic action of melphalan and "activated" cyclophosphamide against cultured tumor cells by centrophenoxine.

1977 • 8 citations

Host immune potentiation of drug responses to a murine mammary adenocarcinoma. II. Effect of melphalan therapy on the host immune system

1976 • 6 citations

Effect of hapten plus antihapten-tumor serum treatment on established rat fibrosarcoma.

1979 • 5 citations

The allogeneic effect on tumor growth. II. Suppression of both ascitic and solid MOPC 315 plasmacytoma by the graft-vs-host reaction, with pathologic correlation.

1977 • 5 citations

Development of Resistance to MOPC-315 Plasmacytoma After Intralesional and Intraperitoneal Melphalan Therapy of Tumor-Bearing BALB/c Mice. I. Enhancement of In Vivo Rejection Responses by Combined Chemotherapy-Immunotherapy<xref ref-type="fn" rid="FN2">2</xref>

1982 • 4 citations

Immunomodulation by Cyclophosphamide and its Effect on Eradication of Established Tumors

1984 • 4 citations

[Chemotherapy of multiple myeloma. Review of the recent trials].

1981 • 2 citations